To determine whether the use of TNF-antagonists in this cohort affected the frequency of diagnosis of IBD, the rate of subsequent ulcerative colitis or Crohn’s disease diagnosis after medication use for other AI conditions was evaluated using Fisher’s exact test. The gene discussed is TNF; the disease is ulcerative colitis.